Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreatic Carcinoma”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Study completedNCT04953962
What this trial is testing

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
CanBas Co. Ltd. 36
Not applicableUnknownNCT05244174
What this trial is testing

Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm Malignant Head PrimaryPancreatic Exocrine Insufficiency
Hospital Clinico Universitario de Santiago 82
Not applicableStudy completedNCT04406571
What this trial is testing

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHU de Reims 700
Early research (Phase 1)Ended earlyNCT03957096
What this trial is testing

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Who this might be right for
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more
Seagen Inc. 16
Post-approval studies (Phase 4)Ended earlyNCT03859869
What this trial is testing

Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie 1
Not applicableLooking for participantsNCT07554560
What this trial is testing

Nutrition Intervention for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neuroendocrine Tumor (NET)
Children's Hospital of Philadelphia 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT00220649
What this trial is testing

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Neoplasms
St. Luke's-Roosevelt Hospital Center 25
Not applicableUnknownNCT05980221
What this trial is testing

The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)

Who this might be right for
Pancreatic Exocrine Insufficiency
University Hospital Birmingham NHS Foundation Trust 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554367
What this trial is testing

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Who this might be right for
Exocrine Pancreas CarcinomaMalignant Solid NeoplasmOvarian Low Grade Serous Adenocarcinoma+2 more
National Cancer Institute (NCI) 199
Testing effectiveness (Phase 2)UnknownNCT01728818
What this trial is testing

Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours

Who this might be right for
Focus of Study Instead
PD Dr. med. Volker Heinemann 119
Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT07557394
What this trial is testing

A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 80
Not applicableLooking for participantsNCT06651580
What this trial is testing

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Who this might be right for
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center 1,600
Not applicableUnknownNCT04112836
What this trial is testing

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerExocrine Pancreatic InsufficiencyMetastatic Pancreatic Cancer+3 more
Moscow Clinical Scientific Center 186
Testing effectiveness (Phase 2)Ended earlyNCT02985801
What this trial is testing

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Massimo Raimondo, M.D. 16
Very early researchEnded earlyNCT04930991
What this trial is testing

High Dose Omeprazole in Patients With Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Cancer
University of Oklahoma 25
Testing effectiveness (Phase 2)Ended earlyNCT03822936
What this trial is testing

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

Who this might be right for
Cancer of PancreasPancreas AdenocarcinomaResectable Pancreatic Cancer
CNAO National Center of Oncological Hadrontherapy 30
Load More Results